• Reports

      Reports

      Stay ahead and make informed decisions with Delvens insightful analysis on key business and technological trends.

      How We Can help you
      • Healthcare
      • Automotive
      • Chemicals & Materials
      • Aerospace & Defense
      • Semiconductors & Electronics
      • Food & Beverages
      • Pharmaceutical
      • IT & Telecom
      • Energy
      • Consumer Goods & Services
  • Best Practice Guide

      Best Practice Guides

      The Delvens Best Practice Team offers practical tactics, procedures, and resources to help you address the major growth-related dos and don'ts.

      How We Can help you
      • Healthcare
      • Automotive
      • Chemicals & Materials
      • Aerospace & Defense
      • Semiconductors & Electronics
      • Food & Beverages
      • Pharmaceutical
      • IT & Telecom
      • Energy
      • Consumer Goods & Services
  • Expertise

      Expertise

      Delvens' decades of experience helps you to strategize, plan, optimize and win.

      See What we can do
      • Syndicated Research
      • Custom Research
      • Consulting
      • Implementation Support
      • Audio-Video Infographic Workshops
      • Subscription Model
      • Bundle Reports Model
      • Best Practice Guides
  • Innovation

      Innovation

      Gain thought-provoking insights on some of the biggest trends in the world to guide you in the phase of innovation.

      Let's Innovate

      Latest Chronicles

      CMOs

      What Will Matter To CMOs In 2023?

      11th March 2023

      Featured Chronicle

      Environment Society Governance

      Why ESG is more important than ever!

      4th November 2022
  • Innovation
  • Explore

      Explore

      From accelerating growth and providing strategic vision to the world's biggest brands, to lunch-break sneaker shopping on Melrose, and thirsty Thursdays at the local pubs. We have a Hustling atmosphere because growing together should be fun, or why do it?

      Let's Explore Something

      About

      • Who We Are
      • Why Choose Us
      • Research Methodology
      • Careers
      • Contact

      Help

      • Customer FAQs
      • How To Order
      • Delivery Method
      • Return Policy
      • Privacy Policy
      • Terms of Use
  • Newscast

      Blogs

      Digital Future of Europe

      Shaping the Digital Future of Europe

      10th March 2023
      Let's Read

      Press Room

      Telemedicine

      Telemedicine – For the Future

      11th March 2023
      Let's Understand

      Article

      Enterprise Resource Planning (ERP) Market

      16th March 2023
      Let's Study
  • Newscast
      • Blog
      • Article
      • Pressroom
Pharmaceutical Icon

3D Cell Culture Market – Trends Forecast Till 2030

3D Cell Culture Market by Type (Hydrogel, ECM, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharma, Biotech, Research, Cosmetics), and region (North America, Europe, Asia-Pacific, Middle East, and Africa and South America).

  • Published Date : March 2023
  • Base Year Estimate : 2022
  • Report ID : D-PH-3DCCM-1309
  • Format :
  • Number of Pages : 495
  • Domain : Pharmaceutical
  1. Pharmaceutical
  2. 3D Cell Culture Market – Trends Forecast Till 2030
Buy Now Get Free Sample Now
REPORT SYNOPSIS
Market Snapshot Market Overview Delvens Industry Expert's Standpoint Market Portfolio Key Findings Regional Analysis Competitive Landscape Recent Developments Reasons to Acquire Report Scope
Table Of Content Frequently Asked Questions

Market Snapshot

Market Overview

The global 3D Cell Culture Market size is projected to reach a CAGR of 25.4% from 2023-2030.

A 3D cell culture is an in-vitro technique wherein the cells can grow in an artificially created environment. These environments closely resemble the architecture and functioning of the native tissue. 3D cell culture technique helps stimulate cell differentiation, proliferation, and migration by interacting with their three-dimensional surroundings as they would in the in-vivo environment. As 3D cell cultures can mimic the structure, activity, and microenvironment of the in-vivo tissues, this technique has varied applications in the fields of drug screening, regenerative medicine, stem cell therapies, cancer research, and cell biology. The extracellular matrix in 3D cell cultures enables cell–cell communication by direct contact as in an in-vivo environment by secreting cytokines and trophic factors. These factors are changed in a 2D environment that can significantly affect the cell–cell communication, which in turn can alter cell morphology and proliferation. As 2D cultures cannot recapitulate the architecture and complex cellular matrices as in 3D cultures, this technique is gaining popularity in the healthcare research sector. In addition, 3D cell cultures can provide results with improved efficiency and reduce the cost of the overall R&D process.

The increasing product launches of 3D cell cultures by regulatory authorities and key players, respectively are expected to drive the market growth over the forecast period. The increasing R&D activities in 3D cell culture are expected to aid in the growth of the global 3D cell culture market, over the forecast period. Furthermore, the rising prevalence of cancer and infectious diseases will also dominate the market during the forecast period.

On the other hand, the lack of consistency in products such as Extracellular Matrices or Scaffolds is restraining the growth of the market globally.

The COVID-19 pandemic has resulted in nationwide lockdowns, thereby impacting every industry vertical. Likewise, the 3D cell culture market is also affected by the pandemic. The 3D cell culture industry is currently facing newer challenges to cope up with the demand and supply of 3D cell culture components owing to the COVID-19 pandemic. In addition, inconsistent and interrupted supply chain activities and the availability of human resources are expected to impact the market growth. On the contrary, the surge in research practices for developing novel therapies against COVID-19 is serving as a huge opportunity for the key market players. Research associated with stem cell therapies and regenerative medicine has shown promising results for treating the COVID-19 disease, thus, this is expected to compensate for the deleterious impact caused by lockdowns globally. Thus, the overall COVID-19 impact is anticipated to remain moderate for the prominent players in the 3D cell culture market.

Delvens Industry Expert's Standpoint

The market experiences a decline in BPS values as a result of the disadvantage of 3D cell culture against surface 2D cultures during the fluid flow procedure, making it a time-demanding and cost-incurring issue for manufacturers. In terms of macro and industry-based dynamics, the market is prone to changes as a result of medication development and regulatory impositions. In comparison to certain other cell culture methods, 3D cell culture is widely employed due to its ease and novel characteristics. 3D cell culture can be either scaffold-free or scaffold-based. Scaffolds are in charge of providing support for the cells. This market is being propelled ahead by an increased emphasis on offering options for animal testing, an increased emphasis on tailored therapy, an increase in the incidence of chronic illnesses, and an increase in the availability of research funds.

Market Portfolio

Key Findings

  • The technology segment is further fragmented into Scaffold-based 3D Cell Cultures, Scaffold-free 3D Cell Cultures, and Bioreactors. Scaffold-based technology accounted for the largest revenue share. The use of hydrogels as scaffolds in 3-dimensional cell culture-based research enables the incorporation of sophisticated biochemical and mechanical signs as a mirror of the native extracellular matrix. Moreover, the launch of novel products and the increasing need for advancements in hydrogels for providing robust platforms for studying human and cellular physiology are expected to boost market growth in the coming years.
  • The application segment is further segmented into Cancer, Tissue Engineering & Immunohistochemistry, Drug Development, Stem Cell Research, and Others. The cancer segment dominated the market with the largest revenue share. The use of spheroids as model systems during the development of anticancer therapies drives R&D in this segment. Moreover, the use of 3-dimensional cellular models for the study of cancer biology in preclinical testing and screening is expected to increase revenue generation in this segment.
  • The end-user segment is further fragmented into Biotechnology and Pharmaceutical Industries, Research Laboratories and Institutes, Hospitals and Diagnostic Centres, and Others. The biotechnology and pharmaceutical industries segment generated the largest revenue share. 3D cell cultures have advantages in terms of optimal oxygen and nutrient gradients, non-uniform exposure of cells within a spheroid to a drug, and realistic cell-to-cell interactions in comparison to 2D cell culture to study drug candidates. These factors make 3D cell cultures better suited for drug discovery and development, thereby driving the demand.
     
  • The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America led the global market in 2020 and accounted for the highest revenue share. The region will retain its leading position throughout the forecast period on account of the availability of private and government funding for the development of advanced 3D cell culture models, high healthcare spending, and the presence of a large number of universities and research organizations investigating various stem cell-based approaches.

 

Regional Analysis

North America to Dominate the Market

  • North America led the global market in 2021 and accounted for the highest revenue share.
     
  • The region will retain its leading position throughout the forecast period on account of the availability of private and government funding for the development of advanced 3D cell culture models, high healthcare spending, and the presence of a large number of universities and research organizations investigating various stem cell-based approaches.

 

Competitive Landscape

  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • PromoCell GmbH
  • Greiner Bio One International GmbH
  • Corning, Inc.
  • 3D Biomatrix
  • Lonza
  • Avantor Performance Materials, LLC
  • Tecan Trading AG
  • 3D Biotek LLC
  • Global Cell Solutions, Inc.
  • InSphero